Closed System Drug Transfer Device (CSTD) Market to Reach $3.6 Billion, Globally, by 2033 at 15.7% CAGR: Allied Market Research
10 oct. 2024 10h29 HE | Allied Analytics LLP
Wilmington, Delaware, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Closed System Drug Transfer Device (CSTD) Market by Type (Membrane to membrane and...
Oncology/Cancer Drugs Market to Reach $335.2 Billion, Globally, by 2033 at 7.2% CAGR: Allied Market Research
01 août 2024 21h30 HE | Allied Analytics LLP
Wilmington, Delaware, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Oncology/Cancer Drugs Market by Drug Class (Chemotherapy, Targeted Therapy, Immunotherapy...
Emergen logo.png
Ovarian Cancer Drugs Market Size Worth USD 5.35 Billion in 2032 | Emergen Research
28 nov. 2023 11h00 HE | Emergen Research
Vancouver, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The global ovarian cancer drugs market is set to experience substantial expansion, reaching a size of USD 2.40 Billion in 2022 and projecting an...
IRBM_logos-no-strapline.png
IRBM Selected for Participation in National Chemical Biology Consortium
04 avr. 2023 03h00 HE | IRBM
ROME, April 04, 2023 (GLOBE NEWSWIRE) -- IRBM, a drug discovery and early development research institute and global contract research organization, announces that it is joining the Chemical Biology...
logo.jpg
Processa Pharmaceuticals to Host Conference Call to Discuss 2022 Year End Results and Provide Drug Development Update on March 30, 2023 at 4:30 p.m. EST
23 mars 2023 08h30 HE | Processa Pharmaceuticals, Inc.
HANOVER, MD, March 23, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a developer of Next Generation Chemotherapy drugs that provide a better...
Straits Research Pvt Ltd
Oncology Cancer Drugs Market Size is projected to reach USD 288 Billion by 2030, growing at a CAGR of 7.7%: Straits Research
15 août 2022 15h50 HE | Straits Research
New York, United States, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Cancer develops when the body's common control mechanism malfunctions and cannot stop the proliferation of abnormal cells. In this case,...
LOGO.png
RAFA To Add Major Component to the Tashkent Pharma Park
17 déc. 2021 11h34 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and the Czech company “Block” signed an agreement on the implementation of the construction of a...
Straits Research Pvt Ltd
Cancer and Allied Advancements in Chemotherapy – Straits Research
16 sept. 2021 09h00 HE | Straits Research
New York, US, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The chemotherapy market is expected to grow at a compound annual growth rate (CAGR) of 10.4% in the forecast period from 2020 to 2029. The global...
LOGO.png
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs
19 août 2021 10h25 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and one of the world's largest producers of precious metals, Krastsvetmet (Russia, Krasnoyarsk), discussed...
AMR Logo.png
Oncology/Cancer Drugs Market to Reach $222.38 Bn by 2027 at 7.4% CAGR
20 avr. 2021 08h40 HE | Allied Market Research
Portland, OR, April 20, 2021 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Oncology/Cancer Drugs Market by Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy,...